Anti-glomerular basement membrane-antibody disease in a patient treated with adalimumab for rheumatoid arthritis

Anti-glomerular basement membrane-antibody disease in a patient treated with adalimumab for rheumatoid arthritis

Ttumour necrosis factor-alpha (TNF-α) blockade has been linked to the induction of autoimmunity, including autoimmune renal disorders. To our knowledge, there have been no cases of anti-TNF-α therapy associated with anti-glomerular basement membrane (GBM)-antibody disease reported. A 63-year-old mal...

Full description

Bibliographic Details
Main Authors: V Heron, M Nicholson, S Wilkinson, A Young, S Govindarajulu, A Stewart, Sree Krishna Venuthurupalli
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Journal of Clinical and Scientific Research
Subjects:
adalimumab
anti-glomerular basement membrane-antibody disease
rheumatoid arthritis
Online Access:http://www.jcsr.co.in/article.asp?issn=2277-5706;year=2020;volume=9;issue=2;spage=124;epage=127;aulast=Heron

Internet

http://www.jcsr.co.in/article.asp?issn=2277-5706;year=2020;volume=9;issue=2;spage=124;epage=127;aulast=Heron

Similar Items